Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy
- PMID: 3888440
- DOI: 10.1111/j.1365-2222.1985.tb02272.x
Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy
Abstract
Rush immunotherapy with a standardized and lyophilized cocksfoot pollen extract was performed in twenty-three allergic subjects and compared with classical immunotherapy done with an alum adjuved, pyridine extracted cocksfoot pollen extract (fifteen subjects) and a control group of ten patients. The three groups were perfectly matched. Clinical benefits were analysed by means of symptom scores. It was shown that rush immunotherapy gave significantly better results when asthma or rhinitis was considered than either classical immunotherapy (P less than 0.02) or in the control group (P less than 0.01 and 0.02). Skin tests were significantly reduced after rush immunotherapy and did not change in the two other groups. After the pollen season the skin test reactivity was increased in the rush immunotherapy group. Cocksfoot pollen specific IgE did not vary significantly in the three groups. Cocksfoot pollen specific IgG was significantly (P less than 0.05) increased in the rush immunotherapy group before the pollen season and did not vary significantly in the other groups.
Similar articles
-
Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy.Ann Allergy. 1986 Jun;56(6):456-9. Ann Allergy. 1986. PMID: 3717711
-
The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.Pediatr Allergy Immunol. 2006 Sep;17(6):396-407. doi: 10.1111/j.1399-3038.2006.00442.x. Pediatr Allergy Immunol. 2006. PMID: 16925684 Clinical Trial.
-
Rush immunotherapy with sublingual administration of grass allergen extract.Allergol Immunopathol (Madr). 1993 Sep-Oct;21(5):173-8. Allergol Immunopathol (Madr). 1993. PMID: 8160561 Clinical Trial.
-
Rush immunotherapy with a standardized Bermuda grass pollen extract.Ann Allergy. 1989 Aug;63(2):127-35. Ann Allergy. 1989. PMID: 2669567 Clinical Trial.
-
Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.J Allergy Clin Immunol. 2016 Feb;137(2):562-70. doi: 10.1016/j.jaci.2015.05.023. Epub 2015 Jun 30. J Allergy Clin Immunol. 2016. PMID: 26141262 Clinical Trial.
Cited by
-
Immunotherapy in allergic respiratory diseases.Lung. 1990;168 Suppl:1013-24. doi: 10.1007/BF02718239. Lung. 1990. PMID: 2117102 Review.
-
Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air® approach.Clin Transl Allergy. 2023 Jan;13(1):e12215. doi: 10.1002/clt2.12215. Clin Transl Allergy. 2023. PMID: 36705508 Free PMC article.
-
Safety considerations in assessing the role of immunotherapy in allergic disorders.Drug Saf. 1994 Jan;10(1):5-17. doi: 10.2165/00002018-199410010-00002. Drug Saf. 1994. PMID: 8136087 Review.
-
Specific immunotherapy in house dust mite allergy.Clin Rev Allergy Immunol. 1995 Summer;13(2):151-9. doi: 10.1007/BF02758099. Clin Rev Allergy Immunol. 1995. PMID: 7489261 Review. No abstract available.
-
Skin tests.Clin Rev Allergy. 1988 Summer;6(2):211-27. doi: 10.1007/BF02914939. Clin Rev Allergy. 1988. PMID: 3048626 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical